Anidulafungin and hyperkalaemia Patient Reports February 10, 2012

Anidulafungin Side Effects Report #6085679-3
Anidulafungin side effect was reported by a Physician from MEXICO on Feb 10, 2009. Female patient was diagnosed with systemic candida and was treated with Anidulafungin. After drug was administered, patient experienced the following side effects: hyperkalaemia, septic shock. Anidulafungin dosage: 200 MG, 1X/DAY. During the same period patient was treated with LEVOTHYROXINE, METRONIDAZOLE, TRAMADOL HYDROCHLORIDE, FUROSEMIDE, LOPERAMIDE HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Anidulafungin Side Effects Report #6110312-1
Anidulafungin side effect was reported by a Physician from MEXICO on Feb 26, 2009. Female patient was diagnosed with systemic candida and was treated with Anidulafungin. After drug was administered, patient experienced the following side effects: hyperkalaemia, septic shock. Anidulafungin dosage: 200 MG, 1X/DAY. During the same period patient was treated with LEVOTHYROXINE, METRONIDAZOLE, TRAMADOL HYDROCHLORIDE, FUROSEMIDE, LOPERAMIDE HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, OMEPRAZOLE. Patient was hospitalized. Patient died on 02/20/2009.

Anidulafungin Side Effects Report #6127117-8
Anidulafungin side effect was reported by a Physician from MEXICO on Mar 10, 2009. Female patient was diagnosed with systemic candida and was treated with Anidulafungin. After drug was administered, patient experienced the following side effects: hyperkalaemia, septic shock. Anidulafungin dosage: 200 MG, 1X/DAY. During the same period patient was treated with LEVOTHYROXINE, METRONIDAZOLE, TRAMADOL HYDROCHLORIDE, FUROSEMIDE, LOPERAMIDE HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, OMEPRAZOLE. Patient was hospitalized. Patient died on 02/20/2009.